Luuk Wieske

10PUBLICATIONS
34CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityNeurology and neuromuscular diseasesPsychopharmacologyPeripheral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 27, 2026
Intravenous methylprednisolone as add-on induction therapy for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.

Sander R M Bus, Iris N van Doorn, Laura Zambreanu

|Feb 19, 2025
Unique Nerve Tissue-Restricted T-Cell Clones in Chronic Inflammatory Demyelinating Polyneuropathy.

G G A van Lieverloo, D C Anang, M E Adrichem

|Feb 20, 2024
Challenges in the Early Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Adults: Current Perspectives.

Iris N van Doorn, Filip Eftimov, Luuk Wieske

|Aug 30, 2023
Reply: Peripherin is a biomarker of axonal damage in Guillain-Barré syndrome: a pathophysiological annotation.

Stephen Keddie, Duncan Smyth, Ryan Y S Keh

|Jul 12, 2023
Peripherin is a biomarker of axonal damage in peripheral nervous system disease.

Stephen Keddie, Duncan Smyth, Ryan Y S Keh

|Feb 01, 2023
B-cell and T-cell receptor repertoire in chronic inflammatory demyelinating polyneuropathy, a prospective cohort study.

G G A van Lieverloo, A Al-Soudi, L Wieske

Pageof 2